SINGLE PASS
Single Pass is a developer of a disposable bipolar electrocautery device that can cauterize deep tissue through a guide needle.
SINGLE PASS
Industry:
Life Science Medical
Founded:
2021-01-01
Address:
Lake Forest, California, United States
Country:
United States
Website Url:
http://www.singlepass.co
Status:
Active
Total Funding:
460 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Contego Medical
Contego Medical develops a family of novel embolic protection devices.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Investors List
Kyto Technology and Life Science Inc
Kyto Technology and Life Science Inc investment in Seed Round - Single Pass
Tech Coast Angels
Tech Coast Angels investment in Seed Round - Single Pass
Official Site Inspections
http://www.singlepass.co
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Single Pass"
Single Pass, Inc. | Biopsy Cauterization Device | Orange …
Single Pass, Inc. offers the first disposable biopsy cauterization device. It prevents bleeding by safely cauterizing deep tissue through a guide needle, promising swift, easy, and safe biopsy procedures.See details»
Single Pass - Crunchbase Company Profile & Funding
Single Pass is a developer of a disposable bipolar electrocautery device.See details»
SinglePass 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for SinglePass. Use the PitchBook Platform to explore the full profile.See details»
Media | SinglePass
Single Pass is headquartered in Lake Forest, California, and has pioneered a patented battery-powered electrocautery device for cauterizing deep tissue biopsy channels post solid organ procedures. With a management team boasting …See details»
Single Pass, Inc. | Electrocautery Biopsy | Stop Bleeding …
Apr 8, 2024 - Print - PDF Mobile - PDF Single Pass – Improving the Safety of Biopsy Procedures with Their Revolutionary Cautery Device Bill Colone CEO Single Pass, Inc. www.singlepass.co Contact: Bill Colone, CEO 602-618-3377 …See details»
Our Team | SinglePass
Single Pass is headquartered in Lake Forest, California, and has pioneered a patented battery-powered electrocautery device for cauterizing deep tissue biopsy channels post solid organ …See details»
Singlepass - Overview, News & Similar companies | ZoomInfo.com
View Singlepass (www.singlepass.co) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
A Roadmap to Serial Medtech Entrepreneurship: …
In the heart of Orange County, SinglePass, a fresh startup in medtech, is on the cusp of disrupting the way we conduct deep tissue biopsies. At its helm is Bill Colone, a serial entrepreneur with a track record of successfully leading …See details»
Single Pass, Inc. Overview | SignalHire Company Profile
Summary The Kronos Electrocautery device efficiently seals biopsy channels, enhancing safety for high-risk patients and enabling the use of larger needles for more substantial tissue …See details»
Singlepass, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Singlepass, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Single Pass, Inc. | Startup Profile and Investments - Bounce Watch
Single Pass is a startup that has caught the attention of venture capitalists with its pioneering unique electrocautery device. The device focuses on ensuring safe and efficient deep tissue …See details»
Single Pass Closes Seed Funding Round - PR Newswire
LAKE FOREST, Calif., July 9, 2021 /PRNewswire/ -- Bill Colone, CEO, announced today the closing of the seed financing round for Single Pass, Inc. (www.singlepass.co). Single Pass has …See details»
Orange County's Single Pass Treats First Patients in North America
Oct 24, 2022 Single Pass Treats First Patients in North America LAKE FOREST, Calif., Oct. 19, 2022 /PRNewswire/ -- Single Pass, Inc. CEO, Bill Colone, announced treatment of the first …See details»
A Milestone for OC's Single Pass, Inc.: FDA Clears Kronos Biopsy ...
The company previously achieved the CE Mark under the EU MDR regulations, as now the Kronos device is now commercially available globally. "We are thrilled to have received FDA …See details»
SinglePass Inc.’s Patented Device Redefines Biopsy Safety
Nov 3, 2023 About SinglePass Inc. SinglePass Inc. is a pioneering medical device manufacturing company dedicated to improving the safety of biopsy procedures.See details»
OC's Single Pass Announces Clinical Milestone
Feb 26, 2024 For more information about the Single Pass KRONOS device, please visit https://singlepass.co/ Single Pass is a medical technology company dedicated to developing …See details»
SinglePass Inc. Redefining Biopsy Procedures for Enhanced Patient ...
Nov 2, 2023 The company recognized a critical gap in risk management for biopsies, and its innovative device addresses this concern with unmatched efficiency. SinglePass Inc.’s core …See details»
Contact Us | SinglePass
Fill out a product inquiry to get more information on getting the Single Pass device into your hands. A purpose-built solution to a common problem. Setting a standard of care for …See details»
The problem - singlepass.co
Each year, millions undergo solid organ biopsy procedures, occasionally encountering adverse events linked to needle size and patient risk factors like blood disorders or anticoagulation …See details»
Testimonals | SinglePass
"The device offers a breakthrough solution for patients undergoing percutaneous biopsy who are at high risk of bleeding complications. Knowing such a solution exists puts both patients and …See details»